世界の医療用ドライパウダー吸入器(DPI)市場2023年:企業・地域・タイプ・用途別分析

【英語タイトル】Global Medical Dry Powder Inhalers (DPIs) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが出版した調査資料(GIR23SM7268)・商品コード:GIR23SM7268
・発行会社(調査会社):GlobalInfoResearch
・発行日:2023年9月
・ページ数:106
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(注文後2-3日)
・調査対象地域:グローバル
・産業分野:医療機器&消耗品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥528,960見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,220 ⇒換算¥793,440見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,057,920見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

GlobalInfoResearchの最新の調査によると、世界の医療用ドライパウダー吸入器(DPI)の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の医療用ドライパウダー吸入器(DPI)市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 医療用ドライパウダー吸入器(DPI)の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

医療用ドライパウダー吸入器(DPI)市場はタイプと用途によって区分されます。2018年~2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・単回投与、複数回投与

用途別セグメント
・喘息、COPD、その他

主要な市場プレーヤー
・GlaxoSmithKline、AstraZeneca、Boehringer Ingelheim、Chiesi、Cipla、3M、Hovione、Mannkind、Mylan、Novartis、Schering/Merck、Teva、Vectura

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、医療用ドライパウダー吸入器(DPI)製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な医療用ドライパウダー吸入器(DPI)メーカーの企業概要、2019年~2022年までの医療用ドライパウダー吸入器(DPI)の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な医療用ドライパウダー吸入器(DPI)メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年~2029年までの地域別医療用ドライパウダー吸入器(DPI)の販売量、売上、成長性を示しています。
・第5、6章では、2018年~2029年までの医療用ドライパウダー吸入器(DPI)のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2029年までの主要地域での医療用ドライパウダー吸入器(DPI)市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および医療用ドライパウダー吸入器(DPI)の産業チェーンを掲載しています。
・第14、15章では、医療用ドライパウダー吸入器(DPI)の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 医療用ドライパウダー吸入器(DPI)の概要
– タイプ別分析(2018年vs2022年vs2029年):単回投与、複数回投与
– 用途別分析(2018年vs2022年vs2029年):喘息、COPD、その他
– 世界の医療用ドライパウダー吸入器(DPI)市場規模・予測
– 世界の医療用ドライパウダー吸入器(DPI)生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
– GlaxoSmithKline、AstraZeneca、Boehringer Ingelheim、Chiesi、Cipla、3M、Hovione、Mannkind、Mylan、Novartis、Schering/Merck、Teva、Vectura
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年:単回投与、複数回投与
・用途別分析2018年-2029年:喘息、COPD、その他
・医療用ドライパウダー吸入器(DPI)の北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:アメリカ、カナダ、メキシコなど
・医療用ドライパウダー吸入器(DPI)のヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・医療用ドライパウダー吸入器(DPI)のアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・医療用ドライパウダー吸入器(DPI)の南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ブラジル、アルゼンチンなど
・医療用ドライパウダー吸入器(DPI)の中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学(成長要因、阻害要因、トレンド、ポーターズファイブフォース分析)
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of Medical Dry Powder Inhalers (DPIs)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Medical Dry Powder Inhalers (DPIs) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Single Dose
1.3.3 Multi Dose
1.4 Market Analysis by Application
1.4.1 Overview: Global Medical Dry Powder Inhalers (DPIs) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Asthma
1.4.3 COPD
1.4.4 Others
1.5 Global Medical Dry Powder Inhalers (DPIs) Market Size & Forecast
1.5.1 Global Medical Dry Powder Inhalers (DPIs) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Medical Dry Powder Inhalers (DPIs) Sales Quantity (2018-2029)
1.5.3 Global Medical Dry Powder Inhalers (DPIs) Average Price (2018-2029)
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Medical Dry Powder Inhalers (DPIs) Product and Services
2.1.4 GlaxoSmithKline Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GlaxoSmithKline Recent Developments/Updates
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Medical Dry Powder Inhalers (DPIs) Product and Services
2.2.4 AstraZeneca Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AstraZeneca Recent Developments/Updates
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Medical Dry Powder Inhalers (DPIs) Product and Services
2.3.4 Boehringer Ingelheim Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Boehringer Ingelheim Recent Developments/Updates
2.4 Chiesi
2.4.1 Chiesi Details
2.4.2 Chiesi Major Business
2.4.3 Chiesi Medical Dry Powder Inhalers (DPIs) Product and Services
2.4.4 Chiesi Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Chiesi Recent Developments/Updates
2.5 Cipla
2.5.1 Cipla Details
2.5.2 Cipla Major Business
2.5.3 Cipla Medical Dry Powder Inhalers (DPIs) Product and Services
2.5.4 Cipla Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Cipla Recent Developments/Updates
2.6 3M
2.6.1 3M Details
2.6.2 3M Major Business
2.6.3 3M Medical Dry Powder Inhalers (DPIs) Product and Services
2.6.4 3M Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 3M Recent Developments/Updates
2.7 Hovione
2.7.1 Hovione Details
2.7.2 Hovione Major Business
2.7.3 Hovione Medical Dry Powder Inhalers (DPIs) Product and Services
2.7.4 Hovione Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hovione Recent Developments/Updates
2.8 Mannkind
2.8.1 Mannkind Details
2.8.2 Mannkind Major Business
2.8.3 Mannkind Medical Dry Powder Inhalers (DPIs) Product and Services
2.8.4 Mannkind Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Mannkind Recent Developments/Updates
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business
2.9.3 Mylan Medical Dry Powder Inhalers (DPIs) Product and Services
2.9.4 Mylan Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Mylan Recent Developments/Updates
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Medical Dry Powder Inhalers (DPIs) Product and Services
2.10.4 Novartis Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Novartis Recent Developments/Updates
2.11 Schering/Merck
2.11.1 Schering/Merck Details
2.11.2 Schering/Merck Major Business
2.11.3 Schering/Merck Medical Dry Powder Inhalers (DPIs) Product and Services
2.11.4 Schering/Merck Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Schering/Merck Recent Developments/Updates
2.12 Teva
2.12.1 Teva Details
2.12.2 Teva Major Business
2.12.3 Teva Medical Dry Powder Inhalers (DPIs) Product and Services
2.12.4 Teva Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Teva Recent Developments/Updates
2.13 Vectura
2.13.1 Vectura Details
2.13.2 Vectura Major Business
2.13.3 Vectura Medical Dry Powder Inhalers (DPIs) Product and Services
2.13.4 Vectura Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Vectura Recent Developments/Updates
3 Competitive Environment: Medical Dry Powder Inhalers (DPIs) by Manufacturer
3.1 Global Medical Dry Powder Inhalers (DPIs) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Medical Dry Powder Inhalers (DPIs) Revenue by Manufacturer (2018-2023)
3.3 Global Medical Dry Powder Inhalers (DPIs) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Medical Dry Powder Inhalers (DPIs) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Medical Dry Powder Inhalers (DPIs) Manufacturer Market Share in 2022
3.4.2 Top 6 Medical Dry Powder Inhalers (DPIs) Manufacturer Market Share in 2022
3.5 Medical Dry Powder Inhalers (DPIs) Market: Overall Company Footprint Analysis
3.5.1 Medical Dry Powder Inhalers (DPIs) Market: Region Footprint
3.5.2 Medical Dry Powder Inhalers (DPIs) Market: Company Product Type Footprint
3.5.3 Medical Dry Powder Inhalers (DPIs) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Medical Dry Powder Inhalers (DPIs) Market Size by Region
4.1.1 Global Medical Dry Powder Inhalers (DPIs) Sales Quantity by Region (2018-2029)
4.1.2 Global Medical Dry Powder Inhalers (DPIs) Consumption Value by Region (2018-2029)
4.1.3 Global Medical Dry Powder Inhalers (DPIs) Average Price by Region (2018-2029)
4.2 North America Medical Dry Powder Inhalers (DPIs) Consumption Value (2018-2029)
4.3 Europe Medical Dry Powder Inhalers (DPIs) Consumption Value (2018-2029)
4.4 Asia-Pacific Medical Dry Powder Inhalers (DPIs) Consumption Value (2018-2029)
4.5 South America Medical Dry Powder Inhalers (DPIs) Consumption Value (2018-2029)
4.6 Middle East and Africa Medical Dry Powder Inhalers (DPIs) Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2018-2029)
5.2 Global Medical Dry Powder Inhalers (DPIs) Consumption Value by Type (2018-2029)
5.3 Global Medical Dry Powder Inhalers (DPIs) Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2018-2029)
6.2 Global Medical Dry Powder Inhalers (DPIs) Consumption Value by Application (2018-2029)
6.3 Global Medical Dry Powder Inhalers (DPIs) Average Price by Application (2018-2029)
7 North America
7.1 North America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2018-2029)
7.2 North America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2018-2029)
7.3 North America Medical Dry Powder Inhalers (DPIs) Market Size by Country
7.3.1 North America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Country (2018-2029)
7.3.2 North America Medical Dry Powder Inhalers (DPIs) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2018-2029)
8.2 Europe Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2018-2029)
8.3 Europe Medical Dry Powder Inhalers (DPIs) Market Size by Country
8.3.1 Europe Medical Dry Powder Inhalers (DPIs) Sales Quantity by Country (2018-2029)
8.3.2 Europe Medical Dry Powder Inhalers (DPIs) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Medical Dry Powder Inhalers (DPIs) Market Size by Region
9.3.1 Asia-Pacific Medical Dry Powder Inhalers (DPIs) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Medical Dry Powder Inhalers (DPIs) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2018-2029)
10.2 South America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2018-2029)
10.3 South America Medical Dry Powder Inhalers (DPIs) Market Size by Country
10.3.1 South America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Country (2018-2029)
10.3.2 South America Medical Dry Powder Inhalers (DPIs) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Medical Dry Powder Inhalers (DPIs) Market Size by Country
11.3.1 Middle East & Africa Medical Dry Powder Inhalers (DPIs) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Medical Dry Powder Inhalers (DPIs) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Medical Dry Powder Inhalers (DPIs) Market Drivers
12.2 Medical Dry Powder Inhalers (DPIs) Market Restraints
12.3 Medical Dry Powder Inhalers (DPIs) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Medical Dry Powder Inhalers (DPIs) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Medical Dry Powder Inhalers (DPIs)
13.3 Medical Dry Powder Inhalers (DPIs) Production Process
13.4 Medical Dry Powder Inhalers (DPIs) Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Medical Dry Powder Inhalers (DPIs) Typical Distributors
14.3 Medical Dry Powder Inhalers (DPIs) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Medical Dry Powder Inhalers (DPIs) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Medical Dry Powder Inhalers (DPIs) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Medical Dry Powder Inhalers (DPIs) Product and Services
Table 6. GlaxoSmithKline Medical Dry Powder Inhalers (DPIs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. GlaxoSmithKline Recent Developments/Updates
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Major Business
Table 10. AstraZeneca Medical Dry Powder Inhalers (DPIs) Product and Services
Table 11. AstraZeneca Medical Dry Powder Inhalers (DPIs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. AstraZeneca Recent Developments/Updates
Table 13. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 14. Boehringer Ingelheim Major Business
Table 15. Boehringer Ingelheim Medical Dry Powder Inhalers (DPIs) Product and Services
Table 16. Boehringer Ingelheim Medical Dry Powder Inhalers (DPIs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Boehringer Ingelheim Recent Developments/Updates
Table 18. Chiesi Basic Information, Manufacturing Base and Competitors
Table 19. Chiesi Major Business
Table 20. Chiesi Medical Dry Powder Inhalers (DPIs) Product and Services
Table 21. Chiesi Medical Dry Powder Inhalers (DPIs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Chiesi Recent Developments/Updates
Table 23. Cipla Basic Information, Manufacturing Base and Competitors
Table 24. Cipla Major Business
Table 25. Cipla Medical Dry Powder Inhalers (DPIs) Product and Services
Table 26. Cipla Medical Dry Powder Inhalers (DPIs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Cipla Recent Developments/Updates
Table 28. 3M Basic Information, Manufacturing Base and Competitors
Table 29. 3M Major Business
Table 30. 3M Medical Dry Powder Inhalers (DPIs) Product and Services
Table 31. 3M Medical Dry Powder Inhalers (DPIs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. 3M Recent Developments/Updates
Table 33. Hovione Basic Information, Manufacturing Base and Competitors
Table 34. Hovione Major Business
Table 35. Hovione Medical Dry Powder Inhalers (DPIs) Product and Services
Table 36. Hovione Medical Dry Powder Inhalers (DPIs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hovione Recent Developments/Updates
Table 38. Mannkind Basic Information, Manufacturing Base and Competitors
Table 39. Mannkind Major Business
Table 40. Mannkind Medical Dry Powder Inhalers (DPIs) Product and Services
Table 41. Mannkind Medical Dry Powder Inhalers (DPIs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Mannkind Recent Developments/Updates
Table 43. Mylan Basic Information, Manufacturing Base and Competitors
Table 44. Mylan Major Business
Table 45. Mylan Medical Dry Powder Inhalers (DPIs) Product and Services
Table 46. Mylan Medical Dry Powder Inhalers (DPIs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Mylan Recent Developments/Updates
Table 48. Novartis Basic Information, Manufacturing Base and Competitors
Table 49. Novartis Major Business
Table 50. Novartis Medical Dry Powder Inhalers (DPIs) Product and Services
Table 51. Novartis Medical Dry Powder Inhalers (DPIs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Novartis Recent Developments/Updates
Table 53. Schering/Merck Basic Information, Manufacturing Base and Competitors
Table 54. Schering/Merck Major Business
Table 55. Schering/Merck Medical Dry Powder Inhalers (DPIs) Product and Services
Table 56. Schering/Merck Medical Dry Powder Inhalers (DPIs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Schering/Merck Recent Developments/Updates
Table 58. Teva Basic Information, Manufacturing Base and Competitors
Table 59. Teva Major Business
Table 60. Teva Medical Dry Powder Inhalers (DPIs) Product and Services
Table 61. Teva Medical Dry Powder Inhalers (DPIs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Teva Recent Developments/Updates
Table 63. Vectura Basic Information, Manufacturing Base and Competitors
Table 64. Vectura Major Business
Table 65. Vectura Medical Dry Powder Inhalers (DPIs) Product and Services
Table 66. Vectura Medical Dry Powder Inhalers (DPIs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Vectura Recent Developments/Updates
Table 68. Global Medical Dry Powder Inhalers (DPIs) Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 69. Global Medical Dry Powder Inhalers (DPIs) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Medical Dry Powder Inhalers (DPIs) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 71. Market Position of Manufacturers in Medical Dry Powder Inhalers (DPIs), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Medical Dry Powder Inhalers (DPIs) Production Site of Key Manufacturer
Table 73. Medical Dry Powder Inhalers (DPIs) Market: Company Product Type Footprint
Table 74. Medical Dry Powder Inhalers (DPIs) Market: Company Product Application Footprint
Table 75. Medical Dry Powder Inhalers (DPIs) New Market Entrants and Barriers to Market Entry
Table 76. Medical Dry Powder Inhalers (DPIs) Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Medical Dry Powder Inhalers (DPIs) Sales Quantity by Region (2018-2023) & (K Units)
Table 78. Global Medical Dry Powder Inhalers (DPIs) Sales Quantity by Region (2024-2029) & (K Units)
Table 79. Global Medical Dry Powder Inhalers (DPIs) Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Medical Dry Powder Inhalers (DPIs) Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Medical Dry Powder Inhalers (DPIs) Average Price by Region (2018-2023) & (US$/Unit)
Table 82. Global Medical Dry Powder Inhalers (DPIs) Average Price by Region (2024-2029) & (US$/Unit)
Table 83. Global Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Global Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Global Medical Dry Powder Inhalers (DPIs) Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Medical Dry Powder Inhalers (DPIs) Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Medical Dry Powder Inhalers (DPIs) Average Price by Type (2018-2023) & (US$/Unit)
Table 88. Global Medical Dry Powder Inhalers (DPIs) Average Price by Type (2024-2029) & (US$/Unit)
Table 89. Global Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2018-2023) & (K Units)
Table 90. Global Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2024-2029) & (K Units)
Table 91. Global Medical Dry Powder Inhalers (DPIs) Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Medical Dry Powder Inhalers (DPIs) Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Medical Dry Powder Inhalers (DPIs) Average Price by Application (2018-2023) & (US$/Unit)
Table 94. Global Medical Dry Powder Inhalers (DPIs) Average Price by Application (2024-2029) & (US$/Unit)
Table 95. North America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2018-2023) & (K Units)
Table 96. North America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2024-2029) & (K Units)
Table 97. North America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2018-2023) & (K Units)
Table 98. North America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2024-2029) & (K Units)
Table 99. North America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Country (2018-2023) & (K Units)
Table 100. North America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Country (2024-2029) & (K Units)
Table 101. North America Medical Dry Powder Inhalers (DPIs) Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Medical Dry Powder Inhalers (DPIs) Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2018-2023) & (K Units)
Table 104. Europe Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2024-2029) & (K Units)
Table 105. Europe Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2018-2023) & (K Units)
Table 106. Europe Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2024-2029) & (K Units)
Table 107. Europe Medical Dry Powder Inhalers (DPIs) Sales Quantity by Country (2018-2023) & (K Units)
Table 108. Europe Medical Dry Powder Inhalers (DPIs) Sales Quantity by Country (2024-2029) & (K Units)
Table 109. Europe Medical Dry Powder Inhalers (DPIs) Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Medical Dry Powder Inhalers (DPIs) Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2018-2023) & (K Units)
Table 112. Asia-Pacific Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2024-2029) & (K Units)
Table 113. Asia-Pacific Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2018-2023) & (K Units)
Table 114. Asia-Pacific Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2024-2029) & (K Units)
Table 115. Asia-Pacific Medical Dry Powder Inhalers (DPIs) Sales Quantity by Region (2018-2023) & (K Units)
Table 116. Asia-Pacific Medical Dry Powder Inhalers (DPIs) Sales Quantity by Region (2024-2029) & (K Units)
Table 117. Asia-Pacific Medical Dry Powder Inhalers (DPIs) Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Medical Dry Powder Inhalers (DPIs) Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2018-2023) & (K Units)
Table 120. South America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2024-2029) & (K Units)
Table 121. South America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2018-2023) & (K Units)
Table 122. South America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2024-2029) & (K Units)
Table 123. South America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Country (2018-2023) & (K Units)
Table 124. South America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Country (2024-2029) & (K Units)
Table 125. South America Medical Dry Powder Inhalers (DPIs) Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Medical Dry Powder Inhalers (DPIs) Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2018-2023) & (K Units)
Table 128. Middle East & Africa Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2024-2029) & (K Units)
Table 129. Middle East & Africa Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2018-2023) & (K Units)
Table 130. Middle East & Africa Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2024-2029) & (K Units)
Table 131. Middle East & Africa Medical Dry Powder Inhalers (DPIs) Sales Quantity by Region (2018-2023) & (K Units)
Table 132. Middle East & Africa Medical Dry Powder Inhalers (DPIs) Sales Quantity by Region (2024-2029) & (K Units)
Table 133. Middle East & Africa Medical Dry Powder Inhalers (DPIs) Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Medical Dry Powder Inhalers (DPIs) Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Medical Dry Powder Inhalers (DPIs) Raw Material
Table 136. Key Manufacturers of Medical Dry Powder Inhalers (DPIs) Raw Materials
Table 137. Medical Dry Powder Inhalers (DPIs) Typical Distributors
Table 138. Medical Dry Powder Inhalers (DPIs) Typical Customers
List of Figures
Figure 1. Medical Dry Powder Inhalers (DPIs) Picture
Figure 2. Global Medical Dry Powder Inhalers (DPIs) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Medical Dry Powder Inhalers (DPIs) Consumption Value Market Share by Type in 2022
Figure 4. Single Dose Examples
Figure 5. Multi Dose Examples
Figure 6. Global Medical Dry Powder Inhalers (DPIs) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Medical Dry Powder Inhalers (DPIs) Consumption Value Market Share by Application in 2022
Figure 8. Asthma Examples
Figure 9. COPD Examples
Figure 10. Others Examples
Figure 11. Global Medical Dry Powder Inhalers (DPIs) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Medical Dry Powder Inhalers (DPIs) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Medical Dry Powder Inhalers (DPIs) Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Medical Dry Powder Inhalers (DPIs) Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Medical Dry Powder Inhalers (DPIs) Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Medical Dry Powder Inhalers (DPIs) Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Medical Dry Powder Inhalers (DPIs) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Medical Dry Powder Inhalers (DPIs) Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Medical Dry Powder Inhalers (DPIs) Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Medical Dry Powder Inhalers (DPIs) Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Medical Dry Powder Inhalers (DPIs) Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Medical Dry Powder Inhalers (DPIs) Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Medical Dry Powder Inhalers (DPIs) Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Medical Dry Powder Inhalers (DPIs) Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Medical Dry Powder Inhalers (DPIs) Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Medical Dry Powder Inhalers (DPIs) Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Medical Dry Powder Inhalers (DPIs) Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Medical Dry Powder Inhalers (DPIs) Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Medical Dry Powder Inhalers (DPIs) Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Medical Dry Powder Inhalers (DPIs) Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Medical Dry Powder Inhalers (DPIs) Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Medical Dry Powder Inhalers (DPIs) Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Medical Dry Powder Inhalers (DPIs) Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Medical Dry Powder Inhalers (DPIs) Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Medical Dry Powder Inhalers (DPIs) Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Medical Dry Powder Inhalers (DPIs) Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Medical Dry Powder Inhalers (DPIs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Medical Dry Powder Inhalers (DPIs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Medical Dry Powder Inhalers (DPIs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Medical Dry Powder Inhalers (DPIs) Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Medical Dry Powder Inhalers (DPIs) Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Medical Dry Powder Inhalers (DPIs) Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Medical Dry Powder Inhalers (DPIs) Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Medical Dry Powder Inhalers (DPIs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Medical Dry Powder Inhalers (DPIs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Medical Dry Powder Inhalers (DPIs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Medical Dry Powder Inhalers (DPIs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Medical Dry Powder Inhalers (DPIs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Medical Dry Powder Inhalers (DPIs) Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Medical Dry Powder Inhalers (DPIs) Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Medical Dry Powder Inhalers (DPIs) Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Medical Dry Powder Inhalers (DPIs) Consumption Value Market Share by Region (2018-2029)
Figure 53. China Medical Dry Powder Inhalers (DPIs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Medical Dry Powder Inhalers (DPIs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Medical Dry Powder Inhalers (DPIs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Medical Dry Powder Inhalers (DPIs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Medical Dry Powder Inhalers (DPIs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Medical Dry Powder Inhalers (DPIs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Medical Dry Powder Inhalers (DPIs) Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Medical Dry Powder Inhalers (DPIs) Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Medical Dry Powder Inhalers (DPIs) Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Medical Dry Powder Inhalers (DPIs) Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Medical Dry Powder Inhalers (DPIs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Medical Dry Powder Inhalers (DPIs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Medical Dry Powder Inhalers (DPIs) Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Medical Dry Powder Inhalers (DPIs) Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Medical Dry Powder Inhalers (DPIs) Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Medical Dry Powder Inhalers (DPIs) Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Medical Dry Powder Inhalers (DPIs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Medical Dry Powder Inhalers (DPIs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Medical Dry Powder Inhalers (DPIs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Medical Dry Powder Inhalers (DPIs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Medical Dry Powder Inhalers (DPIs) Market Drivers
Figure 74. Medical Dry Powder Inhalers (DPIs) Market Restraints
Figure 75. Medical Dry Powder Inhalers (DPIs) Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Medical Dry Powder Inhalers (DPIs) in 2022
Figure 78. Manufacturing Process Analysis of Medical Dry Powder Inhalers (DPIs)
Figure 79. Medical Dry Powder Inhalers (DPIs) Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source


★調査レポート[世界の医療用ドライパウダー吸入器(DPI)市場2023年:企業・地域・タイプ・用途別分析] (コード:GIR23SM7268)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の医療用ドライパウダー吸入器(DPI)市場2023年:企業・地域・タイプ・用途別分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆